The National Institute for Health and Care Excellence (NICE) in the UK has now approved rTMS
(Repetitive Transcranial Magnetic Stimulation) as an effective and safe method of treating depression for patients in the UK.
The guidelines issued by NICE have not specified or restricted the type of rTMS treatment, which means that practitioners can offer treatment using conventional rTMS – which takes around 40 minutes per session – and/or theta burst, which takes around 5 minutes.
Repetitive Transcranial Magnetic Stimulation is a treatment which uses pulsing magnetic fields to activate brain centers associated with mood.
The treatment has a number of advantages over traditional medication as it is non-invasive. It does not involve surgery, anesthesia or sedation and it does not have the side effects associated with antidepressants.
rTMS has also been shown effective in treating migraine, post-natal depression and pain
Ectron are the UK exclusive distributors of Magventure's rTMS system known as Magvita . This is the only system that has been awarded a CE mark for clinical use.
rTMS treatment is now available from SmartTMS
read more about the approval at: NICE GUIDELINES
The PABLO System – Rehabilitation for the whole body
The PABLO Handsensor is a real allrounder: hand-arm-therapy and assessment device in one, the PABLO does not just facilitate the training of all grip forms of the hand; the built-in sensors also track the grip force and range of motion. Thanks to the cross-system tyroS software, the PABLO offers interactive motion training with audiovisual feedback. The results of each training session are automatically integrated into the data base and the therapy report.
With the following wireless extensions, the PABLO becomes even more versatile:
Ectron is pleased to announce it is partnering Northampton NHS Foundation Trusts - NHS TMS Awareness Day, on Wednesday 4th October 2017.
rTMS is a NICE approved, alternative treatment for patients with Depression and Treatment Resistant Depression.
The course is designed for healthcare professionals who want to know more about rTMS as a treatment, or who may be considering setting up a rTMS clinic.
The day will give you an overview of what rTMS can offer as a treatment, who it may be suitable for, as well as a practical session with MagVentures MagPro System.
Places are strictly limited so please book early to avoid disappointment. Bookings close on Monday 25th September 2017.
Wednesday 4th October
Time: 9:30 am - 4:30pm
Location : Berrywood Hospital - Northamptonshire NHS Foundation Trust.
Course Fee: £200 (payable to Northamptonshire NHS Foundation Trust)
To register your interest please email: email@example.com who will assist you.
Ectron is pleased to announce the launch of Tyromotions new PABLO which is being demonstrated for the very first at RehabWeek 2017, in London.
The PABLO® system is a modern assessment and therapy device for the rehabilitation of patients with impaired motor functions.
MINIMAL MOVEMENTS BECOME VISIBLE
The sensitivity of the Motion sensors enables the tracking of underlying movements. Patients who perform a therapeutic game with minimal movements are more motivated and have more fun during the rehabilitation process.
Activities of daily living can be implemented into the therapy sessions at a high rate of repetition with the PABLO® system. This link to daily routines supports the motivation of the patient and enables his/her motor learning. Sit-to-stand, steering a car, reaching for objects or climbing the stairs are just a few examples.
Creativity has no limits! In combination with the TYROS software every therapeutic movement-exercise can be done in a motivating way and additional feedback using the PABLO® Motionsensors. It‘s simple handling enables a very quick therapy setup with almost no chances for compensation movements.
For more information about the new PABLO please click here
or email firstname.lastname@example.org
Ectron is proud to partner with Dudley and Walsall Mental Health Partnership NHS Trust in the launch of it's TMS clinical trials.
The team from Ectron along with Claus Mathiesen from MagVenture spent two days at the Dorothy Pattison Hospital in Walsall covering the benefits of TMS Therapy for the treatment of depression along with sharing the latest TMS research.
In addition, the whole team gained an understanding of what TMS can offer as a treatment, who it may be suitable for, as well as a practical "hands-on sessions" with the MagVita TMS Therapy system.
Dr Russell Davies and the team will now be going forward and the trial is due to start this month.